Data as of Aug 20
| -0.02 / -1.05%|
The 3 analysts offering 12-month price forecasts for Apricus Biosciences Inc have a median target of 3.50, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +86.17% increase from the last price of 1.88.
The current consensus among 3 polled investment analysts is to Buy stock in Apricus Biosciences Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.